EUVIMEDEUVIMED entdecken
Crossref

The Effect of Syringe-Filling Technique on the Risk for Endophthalmitis after Intravitreal Injection of Anti-VEGF Agents

Maya Finkelstein, Gabriel Katz, Dinah Zur, Alexander Rubowitz, Elad Moisseiev

Ophthalmologica · 2022 · 245 (1) · 34-40

DOI: 10.1159/000518236 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ophthalmologica, online erschienen am 23.07.2021. Verfasst von Maya Finkelstein und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Meir Medical Center, Kfar Saba, Israel. Hauptthemen laut MEDLINE: Endophthalmitis, Syringes. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to compare the risk for post-injection endophthalmitis between different anti-vascular endothelial growth factor (VEGF) agents and syringe preparation techniques.

Methods

A retrospective study of anti-VEGF injections performed in 3 large ophthalmology departments between 2013 and 2019 was conducted. Injections were categorized according to the drug and the syringe-filling technique – prefilling by a hospital pharmacy, prefilling by a good manufacturing practice (GMP) pharmacy, self-drawing from the vial by the injecting physician, and use of a prefilled syringe. Cases of endophthalmitis were identified, and their rates were analyzed.

Results

A total of 197,402 injections were included, and 53 cases of endophthalmitis were identified (0.027% risk). The risk of endophthalmitis following injections with syringes that were prefilled by GMP pharmacies or the manufacturers was significantly lower than that following injections which were self-drawn by the physician (0.019% vs. 0.055%, p < 0.0001). For ranibizumab, risk of endophthalmitis decreased since it became available in a prefilled syringe (0.054% vs. 0.014%, p = 0.066), bordering on statistical significance.

Conclusions

The syringe-filling technique is an important factor determining risk of post-injection endophthalmitis. Use of GMP-grade prefilling by professional pharmacies or the manufacturers significantly reduces this risk and should be the technique of choice for all drugs administered by intravitreal injection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndophthalmitisSyringesAngiogenesis InhibitorsBevacizumabHumansIntravitreal InjectionsRanibizumabRetrospective StudiesVascular Endothelial Growth Factor A

Stichwörter der Autor:innen

AfliberceptAnti-vascular endothelial growth factorBevacizumabEndophthalmitisFillingPrefilled syringeRanibizumabSyringe

Substanzen

Angiogenesis InhibitorsVascular Endothelial Growth Factor ABevacizumabRanibizumab

Autor:innen und Institutionen

  • Department of Ophthalmology, Meir Medical Center, Kfar Saba, Israel.
  • Department of Ophthalmology, Sheba Medical Center, Ramat Gan, Israel.
  • Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Department of Ophthalmology, Tel Aviv Medical Center, Tel Aviv, Israel.

Zitieren

APA

Finkelstein, M., Katz, G., Zur, D., Rubowitz, A., & Moisseiev, E. (2022). The Effect of Syringe-Filling Technique on the Risk for Endophthalmitis after Intravitreal Injection of Anti-VEGF Agents. Ophthalmologica, 245(1), 34-40. https://doi.org/10.1159/000518236

Vancouver

Finkelstein M, Katz G, Zur D, Rubowitz A, Moisseiev E. The Effect of Syringe-Filling Technique on the Risk for Endophthalmitis after Intravitreal Injection of Anti-VEGF Agents. Ophthalmologica. 2022;245(1):34-40. doi:10.1159/000518236

BibTeX
@article{Finkelstein2022,
  author = {Finkelstein, Maya and Katz, Gabriel and Zur, Dinah and Rubowitz, Alexander and Moisseiev, Elad},
  title = {The Effect of Syringe-Filling Technique on the Risk for Endophthalmitis after Intravitreal Injection of Anti-VEGF Agents},
  journal = {Ophthalmologica},
  year = {2022},
  volume = {245},
  number = {1},
  pages = {34--40},
  doi = {10.1159/000518236}
}
Kostenlos starten →